Your browser doesn't support javascript.
loading
Treatment of VLCAD-Deficient Patient Fibroblasts with Peroxisome Proliferator-Activated Receptor δ Agonist Improves Cellular Bioenergetics.
D'Annibale, Olivia M; Phua, Yu Leng; Van't Land, Clinton; Karunanidhi, Anuradha; Dorenbaum, Alejandro; Mohsen, Al-Walid; Vockley, Jerry.
Afiliação
  • D'Annibale OM; Division of Genetic and Genomic Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA.
  • Phua YL; Department of Human Genetics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA 15261, USA.
  • Van't Land C; Division of Genetic and Genomic Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA.
  • Karunanidhi A; Division of Genetic and Genomic Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA.
  • Dorenbaum A; Division of Genetic and Genomic Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA.
  • Mohsen AW; Reneo Pharmaceuticals, Inc., 18575 Jamboree Road Suite 275-S, Irvine, CA 92612, USA.
  • Vockley J; Division of Genetic and Genomic Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA.
Cells ; 11(17)2022 08 24.
Article em En | MEDLINE | ID: mdl-36078043

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acil-CoA Desidrogenase de Cadeia Longa / PPAR delta Limite: Adolescent / Adult / Child / Humans Idioma: En Revista: Cells Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acil-CoA Desidrogenase de Cadeia Longa / PPAR delta Limite: Adolescent / Adult / Child / Humans Idioma: En Revista: Cells Ano de publicação: 2022 Tipo de documento: Article